The article “EULAR: Updated scleroderma guidance focuses on new treatments, approaches,” published June 23, 2015, misstated the recommendation given for glucocorticoid use in scleroderma renal crisis. The article should have said that the recommendations continue to advise against using glucocorticoids in this patient population, based on retrospective study data.
